Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

599.47 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Medpace Stock Shows Rising Price Performance With Jump To 83 RS Rating ↗

August 17, 2021

Medpace sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

Medpace Holdings, Inc. Common Stock (MEDP) Q2 2021 Earnings Call Transcript ↗

July 27, 2021

MEDP earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Medpace Hldgs: Q2 Earnings Insights ↗

July 26, 2021

Shares of Medpace Hldgs (NASDAQ:MEDP) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 65.62% year over year...

Via Benzinga

Medpace Holdings, Inc. Announces Senior Leadership Changes

July 26, 2021

From Medpace Holdings, Inc.

Via Business Wire

Medpace Holdings, Inc. Reports Second Quarter 2021 Results

July 26, 2021

From Medpace Holdings, Inc.

Via Business Wire

Stocks That Hit 52-Week Highs On Thursday ↗

April 15, 2021

Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:...

Via Benzinga

Earnings Scheduled For July 26, 2021 ↗

July 26, 2021

Companies Reporting Before The Bell • Otis Worldwide (NYSE:OTIS) is estimated to report quarterly earnings at $0.71 per share on revenue of $3.45 billion. •...

Via Benzinga

Earnings Outlook For Medpace Hldgs ↗

July 23, 2021

Medpace Hldgs (NASDAQ:MEDP) announces its next round of earnings this Monday, July 26. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement...

Via Benzinga

Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021

May 27, 2021

From Medpace Holdings, Inc.

Via Business Wire

3 Top Healthcare Stocks to Buy Right Now ↗

May 20, 2021

These three healthcare stocks have proven that growth and long-term trends are on their side.

Via The Motley Fool

Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference

May 18, 2021

From Medpace Holdings, Inc.

Via Business Wire

Cramer Advises Viewers On Fastly, Wells Fargo And More ↗

May 06, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he expects more downgrades for Fastly Inc (NYSE: FSLY) on Thursday. He can't recommend the stock. Cramer...

Via Benzinga

52 Biggest Movers From Yesterday ↗

April 28, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (...

Via Benzinga

Medpace Holdings, Inc. Common Stock (MEDP) Q1 2021 Earnings Call Transcript ↗

April 27, 2021

MEDP earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 27, 2021

Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1...

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

Medpace Holdings, Inc. Reports First Quarter 2021 Results

April 26, 2021

From Medpace Holdings, Inc.

Via Business Wire

Three Medical Stocks To Watch, Including One With A Potential Breakout ↗

April 22, 2021

Two have recent breakouts under their belts while a third is eyeing a fresh buy point.

Via Investor's Business Daily

Earnings Scheduled For April 26, 2021 ↗

April 26, 2021

Companies Reporting Before The Bell • Albertsons Companies (NYSE:ACI) is projected to report quarterly earnings at $0.51 per share on revenue of $15.63 billion....

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Medpace Holdings Stock At The Top Of Buy Range With Earnings On Deck ↗

April 20, 2021

Medpace is in a potential buy range with its next earnings report scheduled for Apr. 26. The medical stock is about 3% above a 177.22 buy point from a second-stage... Read More

Via Investor's Business Daily

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs ↗

April 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗

April 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead ↗

April 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.